Overview of Avalet-20mg (Avatrombopag)
Avalet-20mg is a prescription medication containing Avatrombopag as its active ingredient. It belongs to a class of drugs known as thrombopoietin receptor agonists (TPO-RAs), which stimulate platelet production in the bone marrow. This medication is commonly used for treating thrombocytopenia (low platelet count) in patients with chronic liver disease or immune thrombocytopenia (ITP).
What is Avatrombopag?
Avatrombopag is a small-molecule thrombopoietin receptor agonist that helps increase platelet production. It is primarily prescribed to reduce the need for platelet transfusions in patients undergoing medical procedures or suffering from chronic immune thrombocytopenia.
Uses of Avalet-20mg (Avatrombopag)
Avalet-20mg is prescribed for the following medical conditions:
1. Chronic Immune Thrombocytopenia (ITP)
Used to treat adults with chronic ITP, a condition where the immune system destroys platelets, leading to excessive bruising and bleeding.
Helps maintain an adequate platelet count to prevent severe complications.
2. Thrombocytopenia in Patients with Chronic Liver Disease
Given to patients with chronic liver disease to prepare them for scheduled medical or dental procedures.
Reduces the risk of bleeding by boosting platelet production.
How Avalet-20mg Works
Avalet-20mg mimics the action of thrombopoietin, a natural protein in the body responsible for platelet production. By activating thrombopoietin receptors in the bone marrow, Avalet-20mg increases platelet levels, thereby reducing the risk of excessive bleeding.
Dosage and Administration
The dosage of Avalet-20mg depends on the patient’s condition, platelet count, and medical history.
For Chronic Immune Thrombocytopenia:
The usual starting dose is 20 mg once daily.
The dose may be adjusted based on the patient’s platelet count response.
Treatment duration varies depending on the patient’s response and doctor’s recommendation.
For Thrombocytopenia in